What You Should Know:
– Epic launches Life Sciences program, expanding its work to bring together the disconnected parts of healthcare.
– The Epic Life Sciences program is built to help providers, pharmaceutical companies, and medical device manufacturers recruit research participants, expand clinical trial access to underrepresented communities, and speed up the development of new therapies.
Unifying Clinical Research with Care Delivery
Providers across the world use Epic to conduct more than 100,000 active research studies with 4.7 million patients. While these organizations are leaders in health research, there are opportunities to accelerate the speed of medical advancement by improving how patients, providers, and sponsors interact. Today, many clinical trials use study-specific and disconnected systems that result in duplicative effort and poor communication—inefficiencies that can discourage patients and providers from participating in research.
The initial focus of the Life Sciences program includes:
– Matching participating providers with clinical trial opportunities suited to the makeup of their patient populations.
– Sending participating providers purpose-built Cosmos searches to help them validate whether a trial is right for them without the need to develop their own queries.
– Making clinical trials accessible to more provider groups by lowering the technical and staffing barriers to study activation.
– Increasing clinical trial efficiency by eliminating duplicative workflows and connecting researchers, care teams, patients, and sponsors through a single system.
– Supporting clinicians with point-of-care insights into when their patients might qualify for a clinical trial and applying predictive models to assist with the timing of therapy administration.
“The first stage of the Life Sciences program, clinical trial matchmaking, is available today and provider organizations in the Epic community are already signing up,” said Seth Howard, vice president of research and development at Epic.
